Your browser is no longer supported. Please, upgrade your browser.
Settings
FWP Forward Pharma A/S daily Stock Chart
FWP [NASD]
Forward Pharma A/S
Index- P/E- EPS (ttm)-0.18 Insider Own- Shs Outstand47.54M Perf Week-0.22%
Market Cap56.92M Forward P/E- EPS next Y- Insider Trans- Shs Float23.55M Perf Month2.77%
Income-8.70M PEG- EPS next Q- Inst Own20.70% Short Float0.04% Perf Quarter15.13%
Sales- P/S- EPS this Y-104.00% Inst Trans- Short Ratio0.49 Perf Half Y-43.52%
Book/sh1.73 P/B0.69 EPS next Y- ROA-2.00% Target Price37.00 Perf Year-39.53%
Cash/sh- P/C- EPS next 5Y21.00% ROE-2.40% 52W Range0.71 - 4.45 Perf YTD53.51%
Dividend- P/FCF- EPS past 5Y23.40% ROI- 52W High-73.09% Beta2.71
Dividend %- Quick Ratio74.50 Sales past 5Y- Gross Margin- 52W Low68.62% ATR0.06
Employees5 Current Ratio74.50 Sales Q/Q- Oper. Margin- RSI (14)46.18 Volatility1.39% 4.50%
OptionableNo Debt/Eq0.00 EPS Q/Q-117.80% Profit Margin- Rel Volume0.14 Prev Close1.18
ShortableYes LT Debt/Eq0.00 EarningsApr 30 BMO Payout- Avg Volume18.01K Price1.20
Recom- SMA20-0.37% SMA50-4.99% SMA200-31.88% Volume2,553 Change1.47%
Apr-03-17Downgrade JMP Securities Mkt Outperform → Mkt Perform
Apr-03-17Downgrade Jefferies Buy → Hold
May-26-15Reiterated RBC Capital Mkts Outperform $40 → $45
May-13-15Reiterated RBC Capital Mkts Outperform $33 → $40
May-07-15Reiterated Jefferies Buy $40 → $43
Apr-24-15Reiterated Leerink Partners Outperform $43 → $53
Apr-20-15Reiterated Leerink Partners Outperform $40 → $43
Nov-10-14Initiated RBC Capital Mkts Outperform $33
Apr-04-19 04:30PM  Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018 GlobeNewswire -6.29%
Mar-27-19 08:30AM  Forward Pharma to Participate in the DKBIO2019 Life Science Investor Conference GlobeNewswire
Oct-24-18 11:11AM  Forward Pharma loses appeal in Tecfidera patent dispute with Biogen Reuters -11.21%
10:53AM  Forward Pharma loses appeal in Tecfidera patent dispute with Biogen Reuters
10:42AM  Forward Pharma Provides Update on the Decision of the Federal Circuit in its Appeal of the U.S. Patent Interference GlobeNewswire
10:20AM  Forward Pharma loses appeal in Tecfidera patent dispute with Biogen Reuters
Sep-28-18 07:30AM  Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Conference GlobeNewswire +6.05%
Sep-20-18 09:02AM  The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut Benzinga
Sep-19-18 04:20PM  Forward Pharma Reports Financial and Operational Results from the First Six Months of 2018 GlobeNewswire
Aug-23-18 08:00AM  Forward Pharma to Participate in the LSX Nordic Congress GlobeNewswire
May-23-18 08:20AM  Today's Research Reports on Trending Tickers: Geron and Forward Pharma ACCESSWIRE -28.61%
May-07-18 04:30PM  Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent GlobeNewswire
Apr-30-18 04:40PM  Forward Pharma Reports Full-Year 2017 Financial and Operational Results GlobeNewswire -7.55%
Feb-07-18 07:30AM  Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference GlobeNewswire
Jan-29-18 10:44AM  Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent GlobeNewswire -27.80%
Dec-21-17 05:00PM  Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit GlobeNewswire +5.13%
Nov-29-17 04:30PM  Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018 GlobeNewswire
Nov-27-17 07:30AM  Forward Pharma to Participate in Investor Conferences in December GlobeNewswire
Nov-22-17 04:30PM  Forward Pharma Announces Completion of Corporate Restructuring Plan GlobeNewswire
Nov-15-17 08:02AM  Best-In-Class Undervalued Stocks Simply Wall St.
Nov-09-17 04:30PM  Forward Pharma to Participate in the Nordic-American Life Science Conference GlobeNewswire
Oct-09-17 07:40AM  Featured Company News - AVEO Declares Completion of TIVO-3 Study Futility Analysis ACCESSWIRE
Sep-26-17 04:15PM  Forward Pharma Reports Financial and Operational Results from the First Six Months of 2017 GlobeNewswire
Sep-13-17 08:10AM  Today's Research Reports on Stocks to Watch: Atossa Genetics and Forward Pharma ACCESSWIRE -10.30%
Sep-08-17 08:56AM  Is It Time To Buy Forward Pharma A/S (FWP)? Simply Wall St.
Sep-05-17 05:00PM  Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit GlobeNewswire
Sep-01-17 07:00AM  Forward Pharma Board of Directors Approves Capital Reduction and Returns EUR 917.7 Million to Shareholders GlobeNewswire
Aug-02-17 04:45PM  Forward Pharma Obtains Shareholder Approval of the Planned Capital Reduction at the Extraordinary General Meeting GlobeNewswire
Jul-18-17 08:05AM  Forward Pharma announces planned distribution of EUR 19.45 per share to Shareholders GlobeNewswire
Jun-14-17 08:00AM  Forward Pharma CEO to Present at the JMP Securities 2017 Life Sciences Conference on June 20, 2017 GlobeNewswire
Jun-02-17 08:30AM  Forward Pharma CEO to Present at the Jefferies 2017 Global Healthcare Conference on June 6, 2017 GlobeNewswire
May-31-17 08:30AM  Forward Pharma Appeals the Initial Decision in the U.S. Patent Interference to the Federal Circuit GlobeNewswire
May-01-17 08:30AM  Forward Pharma CEO to Present at the 42nd Annual Deutsche Bank Health Care Conference on May 4, 2017 GlobeNewswire
07:30AM  Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement GlobeNewswire
Apr-18-17 05:15PM  Forward Pharma Reports Fourth Quarter and Year End 2016 Financial and Operational Results GlobeNewswire
Apr-07-17 08:33AM  Should Forward Pharma (FWP) Be On Your Radar Now? Zacks
Apr-03-17 03:42PM  Acorda, Forward, Biogen Fall On Multiple Sclerosis Drug Fight
06:26AM  Forward Pharma A/S downgraded by JMP Securities and Jefferies
Mar-31-17 06:59PM  Forward Pharma Intends to Appeal Decision in Patent Interference Proceeding with Biogen Inc. GlobeNewswire
05:14PM  Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today Motley Fool
05:14PM  Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today at Motley Fool
02:45PM  Biogen wins another big Tecfidera patent case at bizjournals.com
02:45PM  Biogen wins another big Tecfidera patent case American City Business Journals
01:02PM  Biogen wins Tecfidera U.S. patent dispute with Forward Pharma Reuters
12:27PM  Biogen stock rises, Forward Pharma halted down 20% after patent ruling MarketWatch
12:27PM  Biogen stock rises, Forward Pharma halted down 20% after patent ruling at MarketWatch
12:15PM  Forward Pharma Falls On Biogen Patent Victory Over MS Drug Ingredient Benzinga
12:10PM  Forward Pharma plunges on patent ruling CNBC Videos
Mar-01-17 09:15AM  Forward Pharma Appoints Claus Bo Svendsen as Chief Executive Officer and Plans to Reorganize to Reduce Burn Rate Following the Settlement and License Agreement with Biogen GlobeNewswire
Feb-09-17 08:30AM  Forward Pharma Received US$ 1.25bn pursuant to Settlement and License Agreement with Biogen GlobeNewswire
Feb-03-17 11:03AM  Why Forward Pharma A/S Stock Surged 107% in January Motley Fool
11:03AM  Why Forward Pharma A/S Stock Surged 107% in January at Motley Fool
Feb-02-17 09:30AM  The Zacks Analyst Blog Highlights: Forward Pharma A/S, Pioneer Power Solutions, Hudbay Minerals, Applied Optoelectronics and Ultra Clean Holdings
Feb-01-17 02:22PM  5 Best Performing Stocks of January
09:15AM  Forward Pharma Announces Results of Extraordinary General Meeting GlobeNewswire
Jan-26-17 06:41AM  Biogen profit drops 22 pct due to Tecfidera-related costs
Jan-18-17 12:46PM  Biogen Inc. -- Moody's: Biogen's settlement with Forward Pharma is credit negative at Moody's
08:29AM  Why Forward Pharma A/S Stock Gained 48.2% on Tuesday at Motley Fool
08:02AM  Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit
Jan-17-17 05:23PM  Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today at Motley Fool
12:00PM  Forward Pharma Shares Jump on Biogen License Agreement
11:14AM  Biogen Pays Forward Pharma $1.25 Billion To Settle Tecfidera Suit
11:05AM  Tuesdays Top Biopharma Movers 24/7 Wall St.
11:01AM  Forward Pharma Agrees to Enter Into Settlement and License Agreement with Biogen GlobeNewswire
10:05AM  Biogen to pay $1.25B settlement in multiple sclerosis drug case at bizjournals.com
09:45AM  [$$] Biogen Reaches Settlement and License Agreement for MS Drug at The Wall Street Journal
07:52AM  Forward Pharma stock skyrockets 53% on $1.25 bln cash licensing agreement with Biogen at MarketWatch
Jan-11-17 10:48AM  Will Forward Pharma (FWP) Continue to Surge Higher?
Dec-19-16 05:04PM  Biogen Names Insider New CEO After Five-Month Search, Stock Falls
Dec-15-16 08:15AM  Blog Coverage Protalix Receives Letter Intending Purchase of Alfataliglicerase to Treat Gaucher Patients in Brazil Accesswire
Dec-13-16 05:43AM  Is Forward Pharma A/S (FWP) A Good Stock to Buy? at Insider Monkey
Dec-06-16 10:06AM  Forward Pharma A/S :FWP-US: Earnings Analysis: Q3, 2016 By the Numbers : December 6, 2016
Nov-30-16 04:22PM  Biogen, Forward Square Off In Multiple Sclerosis Patent Battle
Nov-29-16 04:34PM  Forward Pharma reports 3Q loss
04:15PM  Forward Pharma Reports Third Quarter 2016 Financial and Operational Results GlobeNewswire
Nov-02-16 08:00AM  Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November GlobeNewswire
Sep-14-16 08:39AM  Should You Get Rid of Forward Pharma (FWP) Now?
Sep-13-16 03:17PM  Forward Pharma A/S :FWP-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016
Sep-06-16 08:00AM  Forward Pharma CFO to Participate in Three Investor Conferences in September GlobeNewswire
Sep-01-16 08:00AM  Forward Pharma Reports Second Quarter 2016 Financial and Operational Results GlobeNewswire
Jul-20-16 02:51PM  Biogen: This is Getting Annoying at Barrons.com
Jul-11-16 07:16PM  Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics as Price Declines
Jun-08-16 06:02PM  Forward Pharma A/S :FWP-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016
Jun-06-16 04:15PM  Forward Pharma CFO to Participate in Two Investor Conferences in June GlobeNewswire
Jun-02-16 04:15PM  Forward Pharma Reports First Quarter 2016 Financial and Operational Results GlobeNewswire
May-09-16 04:01PM  Forward Pharma Announces Board of Directors Expansion with Appointment of Two New Non-Executive Directors GlobeNewswire
May-02-16 08:30AM  Forward Pharma CFO to Present at the Deutsche Bank Health Care Conference GlobeNewswire
Apr-16-16 01:04PM  FORWARD PHARMA A/S Financials
Apr-12-16 04:15PM  Forward Pharma Reports Fourth Quarter and Year End 2015 Financial and Operational Results GlobeNewswire
Mar-15-16 08:15AM  Forward Pharma (FWP) Jumps: Stock Adds 23.1% in Session
Feb-15-16 10:28AM  Billionaire Seth Klarmans Top Biotech Stock Picks at Insider Monkey
Feb-09-16 09:23AM  Forward Pharma CFO to Participate in Two Investor Conferences in February GlobeNewswire
Dec-08-15 01:08PM  FORWARD PHARMA A/S Financials
Nov-30-15 02:50PM  Is Sturm, Ruger & Company (RGR) Going to Burn These Hedge Funds? at Insider Monkey
Nov-25-15 07:30AM  Forward Pharma Reports Third Quarter 2015 Financial and Operational Results GlobeNewswire
Nov-24-15 10:43AM  Do Hedge Funds Love BJs Restaurants, Inc. (BJRI)? at Insider Monkey
Oct-14-15 10:57AM  What Happened To Billionaire Seth Klarmans Top Biotech Picks In The Third Quarter? at Insider Monkey
Sep-15-15 09:59AM  Diarrhea Dings Xenoport Psoriasis Drug Study Results at TheStreet
Sep-08-15 04:00PM  Forward Pharma Reports Second Quarter 2015 Financial and Operational Results GlobeNewswire
Sep-01-15 09:00AM  Forward Pharma CFO to Participate in Three Investor Conferences in September GlobeNewswire
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.